Association of C-reactive protein with cognitive impairment - PubMed (original) (raw)
Association of C-reactive protein with cognitive impairment
James M Noble et al. Arch Neurol. 2010 Jan.
Abstract
Background: High-sensitivity C-reactive protein (hsCRP) is a biomarker of cardiovascular risk that is suggested to be a biomarker for cognitive impairment.
Objective: To explore the association between hsCRP and cognitive impairment.
Design: Cross-sectional analysis of a population-based community aging study.
Setting: Northern Manhattan, New York, New York.
Other participants: One thousand three hundred thirty-one participants from a longitudinal study of aging without dementia and with available hsCRP and neuropsychological testing data at baseline.
Main outcome measures: Four cognitive scores (memory, visuospatial, executive, and language impairment) derived from a neuropsychological battery. Cognitive impairment was defined by scores below 1.5 SDs of demographically corrected means.
Results: Participants in the highest hsCRP tertile had higher adjusted odds of impaired memory (odds ratio [OR], 1.5; 95% confidence interval [CI], 1.0-2.1; P = .03) than participants in the lowest tertile. Subjects in the highest hsCRP tertile also had greater odds of visuospatial impairment (OR, 1.6; 95% CI, 1.0-2.3; P = .03). Higher hsCRP was not associated with executive or language impairment. Persons with at least 1 APOE epsilon4 allele and hsCRP in the highest tertile had the greatest odds of impaired memory (OR, 2.7; 95% CI, 1.6-4.4).
Conclusions: High hsCRP may be a marker of memory and visuospatial impairment in the elderly. The role of APOE epsilon4 requires further exploration.
Similar articles
- Association of prior stroke with cognitive function and cognitive impairment: a population-based study.
Knopman DS, Roberts RO, Geda YE, Boeve BF, Pankratz VS, Cha RH, Tangalos EG, Ivnik RJ, Petersen RC. Knopman DS, et al. Arch Neurol. 2009 May;66(5):614-9. doi: 10.1001/archneurol.2009.30. Arch Neurol. 2009. PMID: 19433661 Free PMC article. - APOE epsilon4 and cognitive decline in older stroke patients with early cognitive impairment.
Ballard CG, Morris CM, Rao H, O'Brien JT, Barber R, Stephens S, Rowan E, Gibson A, Kalaria RN, Kenny RA. Ballard CG, et al. Neurology. 2004 Oct 26;63(8):1399-402. doi: 10.1212/01.wnl.0000141851.93193.17. Neurology. 2004. PMID: 15505155 - Elevated levels of high-sensitivity C-reactive protein are associated with mild cognitive impairment and its subtypes: results of a population-based case-control study.
Dlugaj M, Gerwig M, Wege N, Siegrist J, Mann K, Bröcker-Preuss M, Dragano N, Moebus S, Jöckel KH, Bokhof B, Möhlenkamp S, Erbel R, Weimar C. Dlugaj M, et al. J Alzheimers Dis. 2012;28(3):503-14. doi: 10.3233/JAD-2011-111352. J Alzheimers Dis. 2012. PMID: 22008268 - APOE ε4 allele is associated with worse performance in memory dimensions of the mini-mental state examination: the Bambuí Cohort Study of Aging.
Quintino-Santos S, Diniz BS, Firmo JO, Moriguchi EH, Lima-Costa MF, Castro-Costa E. Quintino-Santos S, et al. Int J Geriatr Psychiatry. 2015 Jun;30(6):573-9. doi: 10.1002/gps.4186. Epub 2014 Aug 15. Int J Geriatr Psychiatry. 2015. PMID: 25132317
Cited by
- Memory deficits in males and females long after subchronic immune challenge.
Tchessalova D, Tronson NC. Tchessalova D, et al. Neurobiol Learn Mem. 2019 Feb;158:60-72. doi: 10.1016/j.nlm.2019.01.003. Epub 2019 Jan 3. Neurobiol Learn Mem. 2019. PMID: 30611884 Free PMC article. - Systemic inflammation in non-demented elderly human subjects: brain microstructure and cognition.
Arfanakis K, Fleischman DA, Grisot G, Barth CM, Varentsova A, Morris MC, Barnes LL, Bennett DA. Arfanakis K, et al. PLoS One. 2013 Aug 26;8(8):e73107. doi: 10.1371/journal.pone.0073107. eCollection 2013. PLoS One. 2013. PMID: 23991174 Free PMC article. - Brain-derived neurotrophic factor, but not body weight, correlated with a reduction in depression scale scores in men with metabolic syndrome: a prospective weight-reduction study.
Lee IT, Fu CP, Lee WJ, Liang KW, Lin SY, Wan CJ, Sheu WH. Lee IT, et al. Diabetol Metab Syndr. 2014 Feb 13;6(1):18. doi: 10.1186/1758-5996-6-18. Diabetol Metab Syndr. 2014. PMID: 24524285 Free PMC article. - Metformin in Amnestic Mild Cognitive Impairment: Results of a Pilot Randomized Placebo Controlled Clinical Trial.
Luchsinger JA, Perez T, Chang H, Mehta P, Steffener J, Pradabhan G, Ichise M, Manly J, Devanand DP, Bagiella E. Luchsinger JA, et al. J Alzheimers Dis. 2016;51(2):501-14. doi: 10.3233/JAD-150493. J Alzheimers Dis. 2016. PMID: 26890736 Free PMC article. Clinical Trial. - C-reactive protein and risk of cognitive decline: The REGARDS study.
Arce Rentería M, Gillett SR, McClure LA, Wadley VG, Glasser SP, Howard VJ, Kissela BM, Unverzagt FW, Jenny NS, Manly JJ, Cushman M. Arce Rentería M, et al. PLoS One. 2020 Dec 31;15(12):e0244612. doi: 10.1371/journal.pone.0244612. eCollection 2020. PLoS One. 2020. PMID: 33382815 Free PMC article.
References
- Craft S. Insulin resistance syndrome and Alzheimer's disease: age- and obesity-related effects on memory, amyloid, and inflammation. Neurobiol Aging. 2005 Dec;26(Suppl 1):65–69. - PubMed
- Singer G, Granger DN. Inflammatory responses underlying the microvascular dysfunction associated with obesity and insulin resistance. Microcirculation. 2007 Jun-Jul;14(4–5):375–387. - PubMed
- Yanbaeva DG, Dentener MA, Creutzberg EC, Wesseling G, Wouters EF. Systemic effects of smoking. Chest. 2007 May;131(5):1557–1566. - PubMed
- Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med. 2002 Nov 14;347(20):1557–1565. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous